MAM
ASMB icon

Meeder Asset Management’s Assembly Biosciences ASMB Stock Holding History

Meeder Asset Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-61
Closed -$16K – 2161
2020
Q2 		$16K Buy
61
+37
+154% +$8.63K ﹤0.01% 1187
2020
Q1 		$4K Sell
24
-50
-68% -$10.7K ﹤0.01% 1844
2019
Q4 		$17K Sell
74
-9
-11% -$1.66K ﹤0.01% 1402
2019
Q3 		$10K Buy
83
+51
+159% +$7.71K ﹤0.01% 1531
2019
Q2 		$5K Hold
32
– – ﹤0.01% 1652
2019
Q1 		$8K Sell
32
-8
-20% -$2.02K ﹤0.01% 1291
2018
Q4 		$11K Buy
40
+28
+233% +$8.1K ﹤0.01% 1217
2018
Q3 		$6K Buy
12
+10
+500% +$4.68K ﹤0.01% 1280
2018
Q2 		$941 Sell
2
-9
-82% -$4.76K ﹤0.01% 1510
2018
Q1 		$6K Buy
11
+6
+120% +$3.72K ﹤0.01% 1169
2017
Q4 		$2K Buy
+5
New +$2.26K ﹤0.01% 1480

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Meeder Asset Management's ASMB Position: Q3 2020 in Review

Meeder Asset Management sold out of Assembly Biosciences (ASMB) in Q3 2020, closing a stake of 61 shares — an estimated $16K sold.

Meeder Asset Management first reported a position in ASMB in Q4 2017 and held it in 11 quarters. The position peaked at $17K in Q4 2019. 118 funds tracked by Wall St. Rank hold ASMB as of Q3 2020.

  • Meeder Asset Management reported no remaining Assembly Biosciences position as of Q3 2020 after selling out during the quarter.
  • Meeder Asset Management sold 61 Assembly Biosciences shares in Q3 2020, an estimated $16K.
  • Meeder Asset Management first reported a position in Assembly Biosciences in Q4 2017 and held it in 11 quarters.
  • Meeder Asset Management's Assembly Biosciences position peaked at $17K in Q4 2019.
  • 118 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2020.

Based on Meeder Asset Management's 13F filing for Q3 2020, filed 2 Nov 2020.